Zusammenfassung
Das Harnblasenkarzinom tritt mit einer Häufigkeit von ca. 18 Neuerkrankungen pro Jahr und 100 000 Einwohnern in Deutschland auf. Dies entspricht in etwa 3% aller Malignome. Männer sind deutlich häufiger betroffen als Frauen (Prävalenz 3:1). Das Harnblasenkarzinom ist eine Erkrankung des höheren Lebensalters. Nur 5% aller Patienten sind zum Zeitpunkt der Diagnose unter 45 Jahren, das Durchschnittsalter bei Ersterkrankung beträgt 65 Jahre.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Anderstrom C, Johansson A, Nilsson S (1983) A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma. Europ Urol 9: 142–147
Batata MA, Hilaris BS, Kim YS, Lee MZ, Chung S, Whitmore WF (1981) Factors of prognostic and therapeutic significance in patients with bladder carcinoma. Int J Radiat Oncol Biol Phys 7: 575–579
Battermann JJ, Tierie AH (1986) Results of implantation for T 1 and T 2 bladder tumours. Radiother Oncol 5: 85–90
Blandy JP, England HR, Evans SJW et al. (1980) T 3 bladder cancer–the case for salvage cystectomy. Brit J Urol 52: 506–510
Bloom HJG, Hendry WF, Wallace DM, Skeot RG (1982) Treatment of T 3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Brit J Urol 54: 136–151
Boileau MA, Johnson DE, Chan RC, Gonzales MO (1980) Bladder carcinoma: results with preoperative radiation therapy and radical cystectomy. Urology 16: 569–576
Bouffioux C, Denis L, Oosterlinck W et al. (1992) Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of a EORTC randomized trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin. J Urol 148: 297–301
Camey M (1985) Bladder replacement by ileocystoplasty following radical cystectomy. World J Urol 3: 161–165
Catalona WJ (1991) Bladder Cancer. In: Gillenwater JY, Grayhack JT, Howards SS, Duckett JW (eds) Adult and pediatric urology. Mosby, St. Louis, 1135–1183
Cervak J, Cufer T, Kragelj B, Zakotnik B, Stanonik M (1993) Sequential transurethral surgery, multiple drug chemotherapy and radiation therapy for invasive bladder carcinoma: initial report. Int J Radiat Oncol Biol Phys 25: 777–782
Chauvet B, Brewer Y, Felix-Faure C, Davin J-L, Vincent P, Réboul F (1993) Combined radiation therapy and cisplatin for locally advanced carcinoma of the urinary bladder. Cancer 72: 2213–2218
D’Hallewin MA, Baert L, Marijnissen JPA, Star WM (1992) Whole bladder wale photodynamic therapy with in situ loght dosimetry for carcinoma in situ of the bladder. J Urol 148: 1152–1155
Dunst J (1991) Die Radiotherapie im interdisziplinären Behandlungskonzept des Harnblasenkarzinoms. Strahlenther Onkol 167: 563–580
Dunst J, Sauer R, Schrott KM, Kühn R, Wittekind C, Altendorf-Hofmann A (1994) Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys 30: 261–266
Eapen L, Stewart D, Danjoux G et al. (1989) Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer. J Clin Oncol 7: 230–235
Edsmyr F, Anderson L, Esporti PL, Littbrand B, Nilsson B (1985) Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother Oncol 4: 197–203
Fossa SD, Ous S, Berner A (1991) Clinical significance of the „palpable mass“ in patients with muscle-infiltrating bladder cancer undergoing cystectomy after preoperative radiotherapy. Brit J Urol 67: 54–60
Fossa SD, Woehre H, Aass N, Jacobsen AB, Olsen DR, Ous S (1993) Bladder cancer: definitive radiation therapy of muscle-invasive bladder cancer. Cancer 72: 3036–3043
Galleher EP, Young JD, Campbell EW, Wizenberg MJ, Jacobs JA, Millstein DI (1977) Pre-cystectomy radiation for carcinoma of the bladder: 17-year experience. J Urol 118: 179–183
Goffinet DR, Schneider MJ, Glatstein EJ, Ludwig H, Ray GR, Dunnick NR, Bagshaw MA (1975) Bladder cancer: results of radiation therapy in 384 patients. Radiology 117: 149–153
Goodman GB, Hislop TG, Elwood JM, Balfour J (1981) Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. Int J Radiat Oncol Biol Phys 7: 569–573
Greiner R, Skaleric C, Veraguth P (1979) The prognostic significance of ureteral obstruction in carcinoma of the bladder. Int J Radiat Oncol Biol Phys 2: 1095–1100
Hamm B (1994) Lymphknotenstaging bei Prostata-und Harnblasenkarzinomen. Ein radiologisches Dilemma. ROFO 161: 1–2
Hannisdal E, Fossa SD, Host H (1993) Blood tests and prognosis in bladder cancer treated by definitive radiotherapy. Radiother Oncol 27: 117–122
Harada T, Tsuchida S, Nishizawa O, Kigure T, Noto H, Kumazaki T, Kato T (1987) Transcystoscopy intracavitary irradiation for carcinoma of the bladder: technique and preliminary clinical results. J Urol 138: 771–774
Hautmann R, Miller K, de Petrioni R, Wenderoth U (1992) Harnblasenneubildung mit der Ileum-Neoblase. Dtsch Ärztebl 89: 320–323
Heney NM, Ahmed S, Flanagan MJ, Frable W, Gordor P, Hafermann M, Hawkins IR (1983) Superficial bladder cancer: progression and recurrence. J Urol 130: 1083–1086
Henry K, Miller J, Mori M, Loening S, Fallon B (1988) Comparison of transurethral resection to radical therapies for stage B bladder tumors. J Urol 140: 964–967
Herr HW (1987) Conservative management of muscle-infiltrating bladder cancer: prospective experience. J Urol 138: 1162–1163
Herr HW (1994) Urachal carcinoma: the case for extended partial cystectomy. J Urol 151: 365–366
Herr HW, Scher HI (1994) Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. J Clin Oncol 12: 975–980
Housset M, Moulard C, Chretien Y et al. (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11: 2150–2157
Jacobi GH, Hohenfellner R (1983) Radikale Zystektomie beim Harnblasenkarzinom: Indikation, derzeitiger klinischer Stellenwert, eigene Ergebnisse einer Serie ohne Vorbestrahlung. Zuckschwerdt, München
Jacobsen AB, Berner A, Juul M, Ous S, Pettersen EO, Fossa SD (1992) DNA flow cytophotometry and neo-adjuvant chemotherapy/radiotherapy in operable muscle-invasive bladder carcinoma. Eur Urol 22: 316–322
Jakse G, Frommhold H, Nedden DZ (1985) Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder. Cancer 55: 1659–1664
Jakse G, Rauschmeier H, Fritsch E, Frommhold H, Marberger H (1986) Die integrierte Radiotherapie und Chemotherapie des lokal fortgeschrittenen Harnblasenkarzinoms. Akt Urol 17: 68–73
Kamat MR, Kulkarni JN, Tongaonkar HB (1991) Adenocarcinoma of the bladder: study of 14 cases and review of the literature. Brit J Urol 68: 254–257
Koch MO, Coussens DM (1994) Retrospective analysis of outcome in patients with nodal metastasis from transitional cell carcinoma of the lower urinary fract. Urology 43: 317–323
Kock NG, Ghoneim MA, Lycke KG, Mahran MR (1989) Replacement of the bladder by the urethral kock pouch: functional results, urodynamics and radiological features. J Urol 141: 1111–1116
Koloszy Z (1991) Histopathological „self-control“ in trans-urethral resection of bladder tumours. Brit J Urol 67: 162–164
Kragelj B, Jereb B, Kragelj L, Stanonik M (1992) Concurrent vinblastine and radiation therapy in bladder cancer. Cancer 70: 2885–2890
Lamm DL (1993) Fortschritte in der Behandlung des oberflächlichen Harnblasenkarzinoms mit BCG-Immuntherapie–Ergebnisse kontrollierter nordamerikanischer Studien. In: Böhle A, Jocham D (Hrsg) BCG-Therapie des oberflächlichen Harnblasenkarzinoms. Springer, Berlin Heidelberg New York Tokyo, S 12–24
Long RT, Grummon RA, Spratt JS (1972) Carcinoma of the urinary bladder. Cancer 29: 98–105
Lynch TH, Waymont B, Dunn JA, Wallace DMA (1992) Urologists’ attitude to the management of bladder cancer. Brit J Urol 70: 522–525
Maciejewski B, Majewski S (1991) Dose fractionation and tumor repopulation in radiotherapy for bladder cancer. Radiother Oncol 21: 163–170
Marks LB, Kaufman SD, Prout GR, Heney NM, Griffin PP, Shipley WU (1988) Invasive bladder carcinoma: preliminary report of selective bladder preservation by trans-urethral surgery, upfront MCV chemotherapy and pelvic irradiation plus cisplatin. Int J Radiat Oncol Biol Phys 15: 877–883
Mathur VK, Krahn HP, Ramsey EW (1981) Total cystectomy for bladder cancer. J Urol 125: 784–786
Mazeron JJ, Crook J, Chopin D, Abbon CC, Le Bourgois JP, Auvert J, Pierquin B (1988) Conservative treatment of bladder carcinoma by partial cystectomy and interstitial iridium 192. Int J Radiat Oncol Biol Phys 15: 1323–1330
Miller K (1988) Operative Therapie. In: Rüther V, Rassweiler J (Hrsg) Therapie des Harnblasenkarzinoms. Tumor Diagnostik Verlag, Leonberg
Miller LS (1977) Bladder cancer: Superiority of preoperative irradiation and cystectomy in clinical stages B 2 and C. Cancer 39: 973–980
Miller LS, Johnson DE (1973) Megavoltage irradiation for bladder cancer: alone, postoperative or preoperative? Genitourin Cancer 10: 771–782
Montie JR, Straffon RA, Stewart BH (1984) Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol 131: 477–480
Moore MJ, O’Sullivan B, Tannock IF (1988) How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 6: 1736–1745
Moore MJ, Iscode N, Tannock IF (1993) A phase II study of methotrexate, vinblastine, doxorubicin and cisplatin plus recombinant human granulocytemacrophage colony stimulating factors in patients with advanced transitional cell carcinoma. J Urol 150: 1131–1134
Morrison R (1975) The results of treatment of cancer of the bladder–a clinical contribution to radiobiology. Clin Radiol 26: 67–75
Mufti GR, Singh M (1992) Value of random mucosal biopsies in the management of superficial bladder cancer. Eur Urol 22: 288–293
Mulders PFA et al. and members of the Dutch South Eastern Bladder Cancer Study Group (1994) Prognosis and treatment of T 1 G 3 bladder tumours. A prognostic factor analysis of 121 patients. Eur J Cancer 30: 914–917
Näslund I, Nilsson B, Littbrand B (1994) Hyperfractionated radiotherapy of bladder cancer. Acta Oncol 33: 397–402
O’Flynn JD, Schmith JM, Hanson JS (1975) Transurethral resection for the assessment and treatment of vesical neoplasms. Eur Urol 1: 38–40
Orozco RE, Martin AA, Murphy WM (1994) Carcinoma in situ of the urinary bladder. Cancer 74: 115–122
Pagano F, Bassi P, Galetti TP, Meneghini A, Milanic C (1991) Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145: 45–50
Pearse HD, Reed RR, Hodges CV (1978) Radical cystectomy for bladder cancer. J Urol 119: 216–218
Quilty PM, Duncan W (1986a) Primary radical radiotherapy for T 3 transitional cell cancer of the bladder: an analysis of survival and control. Int J Radiat Oncol Biol Phys 12: 853–860
Quilty PM, Duncan W (1986b) Radiotherapy for squamous carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 12: 861–865
Raghavan D, Shipley WU, Garnick MB, Russell PM, Richie JP (1990) Biology and management of bladder cancer. New Engl J Med 322: 1129–1138
Roberts JT, Fossa SD, Richards B et al. (1991) Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T 3 and T 4) transitional cell carcinoma of the bladder. Brit J Urol 68: 162–168
Rotman M, Macchia R, Silverstein M et al. (1987) Treatment of advanced bladder carcinoma with irradiation and concomitant 5-fluorouracil infusion. Cancer 59: 710–714
Rübben H, Jocham D (1991) Therapie des oberflächlichen Blasenkarzinoms. Urologe 30: 2–9
Rübben H, Weißbach L (1989) Systemische Chemotherapy in der Behandlung des Harnblasenkarzinoms. Dtsch Ärztebl 86: 548–550
Rübben H, Lutzeyer W, Fischer N, Deutz F, Lagrange W, Giani G (1988) Natural history and treatment of low and high risk superficial bladder tumors. J Urol 139: 283–285
Russell KJ, Boileau MA, Higano C et al. (1990) Combined 5fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 19: 693–699
Russell KJ, Koh WJ, Russell AH, Giffin BR, Markette KL, Tong DY, Griffin TW (1989) Combined intracavitary and external beam irradiation for superficial transitional cell carcinoma of the bladder: an alternative to cystectomy for patients with recurrence after intervesical chemotherapy. J Urol 141: 30–32
Sauer R, Dunst J, Alterndorf-Hofmann A, Fischer H, Bornhof C, Schrott KM (1990) Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys 19: 687–691
Scher HJ (1990) Chemotherapy for invasive bladder cancer: neoadjuvant versus adjuvant. Semin Oncol 17: 555–565
Schultz PK, Herr HW, Zhang ZF et al. (1994) Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. J Clin Oncol 12: 1394–1401
Shipley WU, Rose MA (1985) Bladder cancer: the selection of patients for treatment by full-dose irradiation. Cancer 55: 2278–2284
Shipley WU, Cummings KB, Coombs LJ et al. (1982) 4000 rad pre-operative irradiation followed by prompt radical cystectomy for invasive bladder carcinoma. J Urol 127: 48–51
Shipley WU, Kaufman SD, Prout GR (1987a) Intraoperative radiation therapy in patients with bladder cancer. Cancer 6o: 1485–1488
Shipley WU, Prout GR, Einstein AB et al. (1987b) Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. J Amer Med Ass 258: 931–935
Shipley WU, Prout GR, Kaufman D, Perrone TL (1987c) Invasive bladder carcinoma: the importance of initial trans-urethral surgery and other significant prognostic factors for improved survival with full-dose irradiation. Cancer 60: 514–520
Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128: 34–36
Smaaland R, Akslen LA, Tonder B, Mehus A, Lote K, Albrektsen G (1991) Radical radiation therapy of invasive and locally advanced bladder carcinoma in elderly patients. Brit J Urol 67: 61–69
Smith JA, Whitmore WF (1981) Regional lymph node metastases from bladder cancer. J Urol 126: 591–593
Soloway MS, Lopez AE, Patel J, Lu Y (1994) Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 73: 1926–1931
Stöckle M, Meyenburg W, Wellek S et al. (1992) Advanced bladder cancer (stages pT 3 b, pT 4 a, pN 1 and pN 2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 148: 302–306
Straus KL, Littman P, Wein A, Whittington R, Tomasuewski JE (1988) Treatment of bladder cancer with interstitial iridium-192 implantation and external beam irradiation. Int J Radiat Oncol Biol Phys 14: 265–271
Swanson DA, von Eschenbach AC, Bracken RB, Johnson DE (1981) Salvage cystectomy for bladder carcinoma. Cancer 47: 2275–2279
Thrasher JB, Trazier HA, Robertson JE, Dodge RK, Paulson DF (1994) Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 73: 1708–1715
Thüroff JW, Alken P, Riedmüller H, Jacobi GH, Hohenfellner R (1988) One hundred cases of Mainz pouch: Continuing experience and evolution. J Urol 140: 283–288
UICC (1987) TNM-Klassifikation maligner Tumoren, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo
Vieweg J, Whitmore WF, Herr HW, Sogani PC, Russo P, Sheinfeld J, Fair WR. (1994) The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. Cancer 73: 3020–3028
Villar A, Munoz J, Aguilo F (1987) External beam irradiation for T 1, T 2–3 and T 4 transitional cell carcinoma of the urinary bladder. Radiother Oncol 9: 209–215
Wallace DM, Bloom JG (1976) The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report). Brit J Urol 48: 587–594
Werf-Messing BHP van der, Friedell GH, Menon RS (1982) Carcinoma of the urinary bladder T 3 NX M o treated by preoperative irradiation followed by simple cystectomy. Int J Radiat Oncol Biol Phys 8: 1849–1855
Whitmore WF, Batata MA, Hilaris BS (1977) A comparative study of two preoperative radiation regimens with cystectomy for bladder cancer. Cancer 40: 1077–1086
Wijnmaalen A, van der Werf-Messing BHP (1986) Factors influencing the prognosis in bladder cancer. Int J Radiat Oncol Biol Phys 12: 559–565
Wishnow KI, Levinson AK, Johnson DE, Tenney DM, Grignon DJ, Ro JY, Ayala AJ (1992) Stage B (P 2/3 A/N o) transitional cell carcinoma of the bladder highly curable by radical cystectomy. Urology 39: 12–16
Woehre H, Ous S, Klevmark B et al. (1993) A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer. Cancer 72: 3044–3051
Yu WS, Sagermann RH, Chung CT (1985) Bladder carcinoma. Experience with radical and preoperative radiotherapy in 421 patients. Cancer 56: 1293–1299
Zietman AL, Shipley WU, Kaufman DS (1993) The combination of cisplatin based chemotherapy and radiation in the treatment of muscle-invading transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 27: 161–170
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dunst, J., Sauer, R. (1996). Harnblase. In: Scherer, E., Sack, H. (eds) Strahlentherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79432-2_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-79432-2_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79433-9
Online ISBN: 978-3-642-79432-2
eBook Packages: Springer Book Archive